Hay 5 veces más probabilidades de un tipo de taquicardia con la COVID que con la vacuna contra la COVID
MARTES, 13 de diciembre de 2022 (HealthDay News) — Una nueva investigación reveló un vínculo entre un síndrome cardiaco menos conocido y la infección con la COVID, y se observó un vínculo mucho más pequeño entre la afección y la vacunación contra la …
Learn MoreModerna, Merck Report on Promising Melanoma Vaccine
TUESDAY, Dec. 13, 2022 (HealthDay News) — Two pharmaceutical companies said Tuesday that they have made notable progress with a vaccine that could prevent melanoma.Moderna, well known for its work on the COVID-19 vaccine, and Merck, which makes the c…
Learn MoreModerna, Merck Report on Promising Melanoma Vaccine
TUESDAY, Dec. 13, 2022 (HealthDay News) — Two pharmaceutical companies said Tuesday that they have made notable progress with a vaccine that could prevent melanoma. Moderna, well known for its work on the COVID vaccine, and Merck, which makes the can…
Learn MoreRapid Heartbeat Condition 5 Times More Likely With COVID Than With COVID Vaccine
TUESDAY, Dec. 13, 2022 (HealthDay News) — New research has revealed a link between a lesser known heart syndrome and COVID infection, with a much smaller link seen between the condition and COVID vaccination. Postural orthostatic tachycardia syndrome…
Learn MoreLa FDA aprueba los refuerzos bivalentes contra la COVID para los niños de a partir de 6 meses
JUEVES, 8 de diciembre de 2022 (HealthDay News) — Los refuerzos bivalentes actualizados contra la COVID-19 cuentan ahora con la aprobación para su uso en niños de incluso apenas 6 meses, anunció hoy la Administración de Alimentos y Medicamentos (FDA)…
Learn MoreJYNNEOS Vaccination Provides Protection Against Mpox
THURSDAY, Dec. 8, 2022 (HealthDay News) — Among men aged 18 to 49 years who are eligible for the JYNNEOS vaccine, mpox incidence is considerably higher among unvaccinated persons versus those who received one or two vaccine doses, according to resea…
Learn MoreMost Common Adverse Events With JYNNEOS Are Nonserious
THURSDAY, Dec. 8, 2022 (HealthDay News) — The JYNNEOS vaccine, which is recommended for persons exposed to or at high risk for exposure to mpox virus, seems safe, with the most common adverse health events reported as nonserious, according to resear…
Learn MoreFDA Approves Bivalent COVID-19 Boosters for Children 6 Months and Older
THURSDAY, Dec. 8, 2022 (HealthDay News) — The updated bivalent COVID-19 boosters are now approved for use in children as young as 6 months of age, the U.S. Food and Drug Administration announced today.Children can receive either a Moderna or Pfizer-B…
Learn MoreFDA OKs Bivalent COVID Boosters for Kids 6 Months and Older
THURSDAY, Dec. 8, 2022 (HealthDay News) — The updated bivalent COVID-19 boosters are now approved for use in children as young as 6 months of age, the U.S. Food and Drug Administration announced today.Children can receive either a Moderna or Pfizer-B…
Learn MoreCOVID-19 Vaccine Prevents Against Reinfection
WEDNESDAY, Dec. 7, 2022 (HealthDay News) — Completing a primary COVID-19 vaccination series is associated with significant protection against reinfection among previously infected individuals, according to a study published online Nov. 22 in PLOS Med…
Learn More